Tender detail
Medicinal product containing lazertinib
Summary
Brno University Hospital is procuring medicinal products containing the active ingredient lazertinib, to be supplied as needed under a framework purchase agreement. The planned contract period is four years.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.